Abstract
The Malassezia genus comprises lipid-dependent yeasts that have long been associated with common skin diseases, and have recently been linked with Crohn's disease and certain cancers. Understanding Malassezia susceptibility to diverse antimicrobial agents is crucial for identifying effective antifungal therapies. Here, we tested the efficacy of isavuconazole, itraconazole, terbinafine, and artemisinin against three Malassezia species: M. restricta, M. slooffiae, and M. sympodialis. Using broth microdilution, we found antifungal properties for the two previously unstudied antimicrobials: isavuconazole and artemisinin. Overall, all Malassezia species were particularly susceptible to itraconazole, with a MIC range from 0.007 to 0.110 μg/mL.
| Original language | English (US) |
|---|---|
| Journal | Microbiology Spectrum |
| Volume | 11 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 2023 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2023 Rathie et al.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Malassezia
- antifungals
- antimicrobial resistance
Fingerprint
Dive into the research topics of 'Antimicrobial Susceptibility Testing for Three Malassezia Species'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS